Your browser doesn't support javascript.
loading
3D CNN-based Deep Learning Model-based Explanatory Prognostication in Patients  with Multiple Myeloma using Whole-body MRI.
Morita, Kento; Karashima, Shigehiro; Terao, Toshiki; Yoshida, Kotaro; Yamashita, Takeshi; Yoroidaka, Takeshi; Tanabe, Mikoto; Imi, Tatsuya; Zaimoku, Yoshitaka; Yoshida, Akiyo; Maruyama, Hiroyuki; Iwaki, Noriko; Aoki, Go; Kotani, Takeharu; Murata, Ryoichi; Miyamoto, Toshihiro; Machida, Youichi; Matsue, Kosei; Nambo, Hidetaka; Takamatsu, Hiroyuki.
Afiliación
  • Morita K; School of Electrical, Information and Communication Engineering, Kanazawa University, Kakumamachi, Kanazawa, Ishikawa, 920-1192, Japan.
  • Karashima S; Institute of Liberal Arts and Science, Kanazawa University, Kanazawa, Japan.
  • Terao T; Department of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan.
  • Yoshida K; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Yamashita T; Department of Radiology, Kanazawa University, Kanazawa, Japan.
  • Yoroidaka T; Division of Internal Medicine, Keiju Kanazawa Hospital, Kanazawa, Japan.
  • Tanabe M; Department of Hematology, Ishikawa Central Prefectural Hospital, Kanazawa, Japan.
  • Imi T; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Zaimoku Y; Department of Hematology, Ishikawa Central Prefectural Hospital, Kanazawa, Japan.
  • Yoshida A; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Maruyama H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Iwaki N; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Aoki G; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Kotani T; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Murata R; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Miyamoto T; Department of Hematology, Ishikawa Central Prefectural Hospital, Kanazawa, Japan.
  • Machida Y; Division of Internal Medicine, Keiju Kanazawa Hospital, Kanazawa, Japan.
  • Matsue K; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Nambo H; Department of Radiology, Kameda Medical Center, Kamogawa, Japan.
  • Takamatsu H; Department of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan.
J Med Syst ; 48(1): 30, 2024 Mar 08.
Article en En | MEDLINE | ID: mdl-38456950
ABSTRACT
Although magnetic resonance imaging (MRI) data of patients with multiple myeloma (MM) are used to predict prognosis, few reports have applied artificial intelligence (AI) techniques for this purpose. We aimed to analyze whole-body diffusion-weighted MRI data using three-dimensional (3D) convolutional neural networks (CNNs) and Gradient-weighted Class Activation Mapping (Grad-CAM), an explainable AI, to predict prognosis and explore the factors involved in prediction. We retrospectively analyzed the MRI data of a total of 142 patients with MM obtained from two medical centers. We defined the occurrence of progressive disease after MRI evaluation within 12 months as a poor prognosis and constructed a 3D CNN-based deep learning model to predict prognosis. Images from 111 cases were used as the training and internal validation data; images from 31 cases were used as the external validation data. Internal validation of the AI model with stratified 5-fold cross-validation resulted in a significant difference in progression-free survival (PFS) between good and poor prognostic cases (2-year PFS, 91.2% versus [vs.] 61.1%, P = 0.0002). The AI model clearly stratified good and poor prognostic cases in the external validation cohort (2-year PFS, 92.9% vs. 55.6%, P = 0.004), with an area under the receiver operating characteristic curve of 0.804. According to Grad-CAM, the MRI signals of the spleen and bones of the vertebrae and pelvis contributed to prognosis prediction. This study is the first to show that image analysis of whole-body MRI using a 3D CNN without any other clinical data is effective in predicting the prognosis of patients with MM.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aprendizaje Profundo / Mieloma Múltiple Límite: Humans Idioma: En Revista: J Med Syst Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aprendizaje Profundo / Mieloma Múltiple Límite: Humans Idioma: En Revista: J Med Syst Año: 2024 Tipo del documento: Article País de afiliación: Japón